Trial Profile
A Pilot, Open Label Trial Assessing the Safety and Efficacy of Betaine in Children With Peroxisome Biogenesis Disorders
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Betaine (Primary)
- Indications Peroxisomal disorders
- Focus Therapeutic Use
- 20 May 2016 Status changed from recruiting to completed.
- 08 Jul 2015 New trial record